MétaCan
Menu
Back to cohort

Predictors of attrition in the treatment of metastatic colorectal cancer (MCRC).

2015· article· en· W2921980052 on OpenAlexaff
Arvin Bahrabadi, Jenny Y. Ruan, Gillian Gresham, Winson Y. Cheung

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsBC Cancer Agency
Fundersnot available
KeywordsMedicineCohortColorectal cancerAttritionCancerInternal medicineLogistic regressionConfoundingPopulationDiseaseProportional hazards modelMedical recordCohort studyOncology

Abstract

fetched live from OpenAlex

e17734 Background: The treatment landscape for many cancers has evolved significantly with the introduction of novel and more efficacious agents. However, the positive impact of these new therapies on outcomes may be limited by patient attrition if individuals are not exposed to later lines of treatment. Using a population-based cohort of MCRC, our aims were to characterize rates of attrition and determine factors associated with failure to receive each line of treatment. Methods: Medical records of patients who were diagnosed with MCRC from 2008 to 2009 and referred to any 1 of the 5 regional cancer centers in British Columbia were merged with systemic therapy data from the provincial pharmacy database. We classified patients into mutually exclusive treatment categories: a) receipt of all available lines of MCRC treatments; b) attrition directly attributable to disease, such as cancer progression or death; and c) attrition secondary to other clinical factors, including toxicities. Multivariate logistic regression models with all-cause attrition as the main outcome were constructed to identify predictors, while adjusting for potential confounders. Results: We identified 302 eligible MCRC patients with complete records: median age was 65 years, 55% were men, 40% were White, 53% were ECOG 0/1, and 41% and 59% were never and ever smokers, respectively. In the entire cohort, only 60 (19%) patients received all lines of MCRC therapies. While worsening disease and death represented the most common cause (40%), other frequent causes of attrition included severe toxicities from prior or ongoing therapies (22%), patient preference (10%), decline in functional status (12%), and presence of significant comorbidities. In multivariate analyses, never smokers (p = 0.01) and individuals with baseline ECOG 2+ (p = 0.01) were significantly more likely to experience treatment attrition. Conclusions: Treatment attrition is a prevalent problem in MCRC and can hinder the benefit of treatment algorithms that rely on a temporal sequence of effective therapies. Some causes of attrition are potentially modifiable and may reflect opportunities for patients to maximize exposure to all lines of therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.017
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.022

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.017
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.263
GPT teacher head0.510
Teacher spread0.247 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicColorectal Cancer Treatments and StudiesFrench-language works237,207